Combined, the 3 main operating expense line items product development, sales and marketing and general and administrative expenses, excluding stock based compensation were 45.2 percent of revenue this fiscal year compared to 45.8% of revenue in FY2023. Operating income for the Q4 of $3,500,000 net income of $3,000,000 and gain per diluted share of $0.11 are slightly less than the prior year 4th quarter gain of $3,400,000 $3,600,000 and $0.14 Adjusted net income normalizing for certain non cash and non recurring charges of $9,000,000 compares favorably to adjusted net income of $6,900,000 in the prior year Q4 and adjusted diluted earnings per share of $0.32 compares favorably to $0.26 For the 2024 Q4, adjusted EBITDA was $11,000,000 compared to $8,100,000 in the year ago quarter. And for the full year fiscal 2024 adjusted EBITDA was $37,100,000 compared to 30,300,000 dollars We are pleased to see our profitability levels end up well ahead of our original FY 2024 plan with adjusted EBITDA coming in at 15.6 percent of revenue. Moving to the balance sheet and cash flow statements. Cash and marketable securities as of March 31, 2024 was $144,900,000 compared to $112,800,000 on March 31, 2023.